Orum Therapeutics Announces U.S. FDA Clearance Of An IND Application For ORM-1153, A Novel CD123-GSPT1 Degrader-Antibody Conjugate
Orum Therapeutics announced FDA clearance for an IND application for ORM-115, a novel CD123-GSPT1 degrader-antibody conjugate, advancing its clinical pipeline.
ESMA Consults On Reporting Framework For Clearing Activity At Recognised Third-country CCPs
ESMA is seeking feedback on a proposed reporting framework for clearing activities at recognized third-country central counterparties, aiming to enhance transparency and oversight.
How Northeast Storms Disrupt Albany’s Trade And Supply-Chain Network
Heavy rain from a Northeast storm is impacting Albany’s trade and supply-chain network, causing delays and operational challenges confirmed on March 2024.